SEC Form 4 · accession 0001171843-19-000756
Anika Therapeutics, Inc. · ANIK
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Sylvia Cheung
Officer — Chief Financial Officer
Period of report
Feb 3, 2019
Accepted (ET)
Feb 6, 2019 · 9:15 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000898437
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Feb 3, 2019 | F | 579 | $37.97 | D | 37,029 | D | |
| Common StockF2 | Feb 4, 2019 | F | 607 | $38.10 | D | 36,422 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Reflects an aggregate of 579 shares of common stock retained by the Issuer to satisfy tax withholding obligations with respect to restricted shares that vested in full on February 3, 2019.
- F2Reflects an aggregate of 607 shares of common stock retained by the Issuer to satisfy tax withholding obligations with respect to restricted shares that vested in full on February 4, 2019.